Catheter impregnation, coating or bonding for reducing central venous catheter related infections in adults

Cochrane Database of Systematic Reviews

Volumn , Issue 3, 2009, Pages

  Lai, Nai Ming ^a   Chaiyakunapruk, Nathorn ^b   Lai, Nai An ^c   O'Riordan, Elizabeth ^d   Pau, Wilson Shu Cheng ^e   Saint, Sanjay ^f  

^a INTERNATIONAL MEDICAL UNIVERSITY   (Malaysia)

^b NARESUAN UNIVERSITY   (Thailand)

^c UNIVERSITY OF ADELAIDE   (Australia)

^d UNIVERSITY OF SYDNEY   (Australia)

^e Hospital Tuanku Jaafar   (Malaysia)

^f UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; CARBON; CHLORHEXIDINE; HEPARIN; MINOCYCLINE; PLATINUM; RIFAMPICIN; SILVER; SULFADIAZINE SILVER;

ANTIBIOTIC THERAPY; CATHETER INFECTION; CATHETER REMOVAL; CENTRAL VENOUS CATHETER; CENTRAL VENOUS CATHETERIZATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; DRUG COST; DRUG SAFETY; HUMAN; RANDOMIZED CONTROLLED TRIAL; REVIEW; SILVER IMPREGNATION;

EID: 70049104553     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD007878     Document Type: Review

References (36)

1. Abdelkefi A, Achour W, Ben Othman T, Ladeb S, Torjman L, Lakhal A, et al. Use of heparin-coated central venous lines to prevent catheter-related bloodstream infection. The Journal of Supportive Oncology 2007;5(6):273-278 [PUBMED: 17624052] (Pubitemid 46995362)
2. Chaiyakunapruk N, Veenstra DL, Lipsky BA, Saint S. Chlorhexidine compared with povidone-iodine solution for vascular catheter-site care: a meta-analysis. Annals of Internal Medicine 2002;136(11):792-801. [PUBMED: 12044127] (Pubitemid 34568649)
3. Cicalini S, Palmieri F, Petrosillo N. Clinical review: New technologies for prevention of intravascular catheter-related infections. Critical Care 2004;8:157-162 [PUBMED: 15153233] (Pubitemid 38735694)
4. Falagas ME, Fragoulis K, Bliziotis IA, Chatzinikolaou I. Rifampicin-impregnated central venous catheters: ameta-analysis of randomized controlled trials. The Journal of Antimicrobial Chemotherapy 2007;59:359-369 [PUBMED: 17255143] (Pubitemid 47073442)
5. Gilbert RE, Harden M. Effectiveness of impregnated central venous catheters for catheter related blood stream infection: a systematic review. Current Opinion in Infectious Diseases 2008;21(3):235-245. [PUBMED: 18448967] (Pubitemid 351620377)
6. Gillies D, O'Riordan L, Carr D, Frost J, Gunning R, O'Brien I. Gauze and tape and transparent polyurethane dressings for central venous catheters. Cochrane Database of Systematic Reviews 2003, Issue 3. [DOI: 10.1002/14651858.CD003827]
7. Gnass SA, Barboza L, Bilicich D, Angeloro P, Treiyer W, Grenovero S, et al. Prevention of central venous catheter-related bloodstream infections using non-technologic strategies. Infection Control and Hospital Epidemiology: The Official Journal of the Society of Hospital Epidemiologists of America 2004;25:675-677 [PUBMED: 15357160] (Pubitemid 39095051)
8. Hanna H, Bahna P, Reitzel R, Dvorak T, Chaiban G, Hachem R, et al. Comparative in vitro efficacies and antimicrobial durabilities of novel antimicrobial central venous catheters. Antimicrobial Agents and Chemotherapy 2006;50(10):3283-3288 [PUBMED: 17005806] (Pubitemid 44527499)
9. Higgins JPT, Thompson SG. Quantifying heterogeneity in a meta-analysis. Statistics in Medicine 2002;21:1539-1558.
10. Higgins JPT, Green S. Cochrane Handbook for Systematic Reviews of Interventions, Version 5.0.0. The Cochrane Collaboration, 2008.
11. Hu KK, Lipsky BA, Veenstra DL, Saint S. Using maximal sterile barriers to prevent central venous catheter-related infection: a systematic evidence-based review. American Journal of Infection Control 2004;32(3):142-146 [PUBMED: 15153925] (Pubitemid 38620835)
12. Jung WK, Koo HC, Kim KW, Shin S, Kim SH, Park YH. Antibacterial activity and mechanism of action of the silver ion in Staphylococcus aureus and Escherichia coli. Applied and Environmental Microbiology 2008;74(7):2171-2178 [PUBMED: 18245232]
13. Kang S, Pinault M, Pfefferle LD, Elimelech M. Single-Walled Carbon Nanotubes Exhibit Strong Antimicrobial Activity. Langmuir 2007;23(17):8670-8673. (Pubitemid 47294266)
14. Khare MD, Bukhari SS, Swann A, Spiers P, McLaren I, Myers J. Reduction of catheter-related colonisation by the use of a silver zeolite-impregnated central vascular catheter in adult critical care. The Journal of Infection 2007;54(2):146-150 [PUBMED: 16678904] (Pubitemid 46075885)
15. Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, et al. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Intensive Care Medicine 2003;29(4):530-538. [PUBMED: 12664219] (Pubitemid 36523666)
16. Mermel LA. New technologies to prevent intravascular catheter-related bloodstream infections. Emerging Infectious Diseases 2001;7:197-199 [PUBMED: 11294705]
17. Narayan R, Abernathy H, Riester L, Berry C, Brigmon R. Antimicrobial properties of diamond-like carbon-silver-platinum nanocomposite thin films. Journal of Materials Engineering and Performance 2005;14:435-440.
18. Norwood S, Ruby A, Civetta J, Cortes V. Catheter-related infections and associated septicemia. Chest 1991;99:968-975 [PUBMED: 2009804]
19. O'Grady NP, Alexander M, Dellinger EP, Gerberding JL, Heard SO, Maki DG, et al. Guidelines for the prevention of intravascular catheter-related infections. Pediatrics 2002;110:e51. [PUBMED: 12415057]
20. Pronovost P, Needham D, Berenholtz S, Sinopoli D, Chu H, Cosgrove S, et al. An intervention to decrease catheter-related bloodstream infections in the ICU. The New England Journal of Medicine 2006;355:2725-2732 [PUBMED: 17192537] (Pubitemid 46021509)
21. Raad II, Hohn DC, Gilbreath BJ, Suleiman N, Hill LA, Bruso PA, et al. Prevention of central venous catheter-related infections by using maximal sterile barrier precautions during insertion. Infection Control and Hospital Epidemiology: The Official Journal of the Society of Hospital Epidemiologists of America 1994;15:231-238 [PUBMED: 8207189]
22. Raad I, Darouiche R, Hachem R, Sacilowski M, Bodey GP. Antibiotics and prevention of microbial colonization of catheters. Antimicrobial Agents and Chemotherapy 1995;39:2397-2400 [PUBMED: 8585715]
23. Raad I, Darouiche R, Hachem R, Mansouri M, Bodey GP. The broad-spectrumactivity and efficacy of catheters coated with minocycline and rifampicin. The Journal of Infectious Diseases 1996;173:418-424 [PUBMED: 8568304] (Pubitemid 26042443)
24. Raad II, Hanna HA. Intravascular catheter-related infections: new horizons and recent advances. Archives of Internal Medicine 2002;162(8):871-878 [PUBMED: 11966337]
25. Ramritu P, Halton K, Collignon P, Cook D, Fraenkel D, Battistutta D, et al. A systematic review comparing the relative effectiveness of antimicrobial-coated catheters in intensive care units. American Journal of Infection Control 2008;36:104-117 [PUBMED: 18313512] (Pubitemid 351296068)
26. The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.0. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2008.
27. Rosenberg B, Van Camp L, Grimley EB, Thomson AJ. The inhibition of growth or cell division in Escherichia coli by different ionic species of platinum(IV) complexes. The Journal of Biological Chemistry 1967;242(6):1347-1352 [PUBMED: 5337590]
28. Rosenthal VD, Maki DG, Salomao R, Moreno CA, Mehta Y, Higuera F, et al. Device-associated nosocomial infections in 55 intensive care units of 8 developing countries. Annals of Internal Medicine 2006;145:582-591 [PUBMED: 17043340] (Pubitemid 46780937)
29. Rosett W, Hodges GR. Antimicrobial activity of heparin. Journal of Clinical Microbiology 1980;11(1):30-34 [PUBMED: 6766462]
30. Saint S, Veenstra DL, Lipsky BA. The clinical and economic consequences of nosocomial central venous catheter-related infection: are antimicrobial catheters useful?. Infection Control and Hospital Epidemiology: The Official Journal of the Society of Hospital Epidemiologists of America 2000;21:375-380 [PUBMED: 10879567]
31. Sampath LA, Tambe SM, Modak SM. In vitro and in vivo efficacy of catheters impregnated with antiseptics or antibiotics: evaluation of the risk of bacterial resistance to the antimicrobials in the catheters. Infection Control and Hospital Epidemiology: The Official Journal of the Society of Hospital Epidemiologists of America 2001;22:640-646 [PUBMED: 11776351]
32. Schmidt SK, Knapp C, Hall G, Longworth D, McMahon JT, Washington JA. Impact of Chlorhexidine-Silver Sulfadiazine-Impregnated central venous catheters on in vitro quantitation of catheter-associated bacteria. Journal of Clinical Microbiology 1996;34:508-511. [PUBMED: 8904403] (Pubitemid 26065764)
33. Shah PS, Shah VS. Continuous heparin infusion to prevent thrombosis and catheter occlusion in neonates with peripherally placed percutaneous central venous catheters. Cochrane Database of Systematic Reviews 2008, Issue 2. [DOI: 10.1002/14651858.CD002772.pub3]
34. Veenstra DL, Saint S, Saha S, Lumley T, Sullivan SD. Efficacy of antiseptic-impregnated central venous catheters in preventing catheter-related bloodstream infection: A meta-analysis. JAMA 1999;281:261-267 [PUBMED: 9918482] (Pubitemid 29058116)
35. Walder B, Pittet D, Tramer MR. Prevention of bloodstream infections with central venous catheters treated with anti-infective agents depends on catheter type and insertion time: evidence from a meta-analysis. Infection Control and Hospital Epidemiology: The Official Journal of the Society of Hospital Epidemiologists of America 2002;23:748-756 [PUBMED: 12517018] (Pubitemid 36020213)
36. Yorganci K, Krepel C, Weigelt JA, Edmiston CE. In vitro evaluation of the antibacterial activity of three different central venous catheters against gram-positive bacteria. European Journal of cClinical Microbiology & Infectious Diseases: Official Publication of the European Society of Clinical Microbiology 2002;21:379-384 [PUBMED: 12072923] (Pubitemid 34810674)